Paciente femenina de 73 años de edad con tromboembolismo pulmonar.
| dc.contributor.advisor | Mazacón Mora, Maite Cecilia | |
| dc.contributor.author | Ramos Mosquera, Samantha Valentina | |
| dc.date.accessioned | 2021-10-21T20:59:56Z | |
| dc.date.available | 2021-10-21T20:59:56Z | |
| dc.date.issued | 2021 | |
| dc.identifier.uri | http://dspace.utb.edu.ec/handle/49000/10286 | |
| dc.description | Pulmonary thromboembolism is also called pulmonary embolism, this happens when there is a detachment of a thrombus that is in an artery or vein and it travels and adheres in pulmonary arteries, it is highly fatal, when it is not diagnosed in time, this in largely because it is a stealthy disease and sometimes difficult to diagnose. Pulmonary thromboembolism can attack anyone, but there are risk factors that increase the risk, such as previous surgeries, people with poor circulation, extended immobilization, among others. The most used treatment is the anticoagulant, as long as there is no type of contraindication, the correct use influences its efficacy in the short or long term. Complementary tests are essential for the use of the correct therapy, the goal of treatment is to avoid recurrent thromboembolism and or its expansion. | es_ES |
| dc.description | Pulmonary thromboembolism is also called pulmonary embolism, this happens when there is a detachment of a thrombus that is in an artery or vein and it travels and adheres in pulmonary arteries, it is highly fatal, when it is not diagnosed in time, this in largely because it is a stealthy disease and sometimes difficult to diagnose. Pulmonary thromboembolism can attack anyone, but there are risk factors that increase the risk, such as previous surgeries, people with poor circulation, extended immobilization, among others. The most used treatment is the anticoagulant, as long as there is no type of contraindication, the correct use influences its efficacy in the short or long term. Complementary tests are essential for the use of the correct therapy, the goal of treatment is to avoid recurrent thromboembolism and or its expansion. | es_ES |
| dc.description.abstract | El tromboembolismo pulmonar también se la denomina embolia pulmonar, esto sucede cuando hay un desprendimiento de un trombo que se encuentra en alguna arteria o vena y este viaja y se adhiere en arterias pulmonares, es altamente mortal, cuando no se diagnostica a tiempo, esto en gran parte porque es una enfermedad sigilosa y algunas veces difíciles de diagnosticar. El tromboembolismo pulmonar puede atacar a cualquier persona, pero existe factores de riesgo que incrementa el riesgo, como cirugías previas, personas con mala circulación, inmovilización extendida entre otros. El tratamiento más usado es el anticoagulante, siempre y cuando no haya algún tipo de contraindicación, el uso correcto influye en su eficacia a corto o largo plazo. Los exámenes complementarios son imprescindibles para la utilización de la terapia correcta, el objetivo del tratamiento es evitar los tromboembolismo recurrentes y o la expansión de este. | es_ES |
| dc.format.extent | 29 p | es_ES |
| dc.language.iso | es | es_ES |
| dc.publisher | Babahoyo: UTB-FCS, 2021 | es_ES |
| dc.rights | Atribución-NoComercial-SinDerivadas 3.0 Ecuador | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ec/ | * |
| dc.subject | Tromboembolismo | es_ES |
| dc.subject | Anticoagulantes | es_ES |
| dc.subject | Heparina | es_ES |
| dc.subject | Trombo | es_ES |
| dc.subject | Traumatismo | es_ES |
| dc.title | Paciente femenina de 73 años de edad con tromboembolismo pulmonar. | es_ES |
| dc.type | bachelorThesis | es_ES |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 Ecuador